|
Volumn 76, Issue 2, 2005, Pages 296-
|
Plasma VEGF as a marker for the diagnosis and treatment of vasculitic neuropathy [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
CORTICOSTEROID;
IMMUNOSUPPRESSIVE AGENT;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR;
AMYOTROPHIC LATERAL SCLEROSIS;
ANGIOGENESIS;
BLOOD SAMPLING;
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DIAGNOSTIC VALUE;
ENZYME IMMUNOASSAY;
GUILLAIN BARRE SYNDROME;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
HYPOXIA;
LETTER;
MUSCLE BIOPSY;
NERVE BIOPSY;
NEUROPATHY;
OUTCOMES RESEARCH;
PATIENT MONITORING;
POLYARTERITIS NODOSA;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
SJOEGREN SYNDROME;
SURAL NERVE;
SYSTEMIC VASCULITIS;
VASCULITIC NEUROPATHY;
BIOLOGICAL MARKERS;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
PERIPHERAL NERVOUS SYSTEM DISEASES;
SENSITIVITY AND SPECIFICITY;
STEROIDS;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULITIS;
|
EID: 12444320406
PISSN: 00223050
EISSN: None
Source Type: Journal
DOI: 10.1136/jnnp.2004.047571 Document Type: Letter |
Times cited : (17)
|
References (5)
|